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Abstract Mg-ATP particles from bovine heart mitochondria
have more than 95% of their F1 in complex with the inhibitor
protein (IF1). The F1^IF1 complex was solubilized and purified.
The question addressed was if this naturally occurring complex
existed as monomers or dimers. Size exclusion chromatography
and electron microscopy showed that most of the purified F1^IF1
complex was a dimer of two F1^IF1. As determined by the
former method, the relative concentrations of dimeric and
monomeric F1^IF1 depended on the concentration of protein
that was applied to the column. Apparently, there is an
equilibrium between the two forms of F1^IF1. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
In the membranes of mitochondria the ATP synthase cata-
lyzes the synthesis of ATP from ADP and inorganic phos-
phate with the energy of electrochemical H gradients. It
consists of a membrane moiety, Fo, that allows the passage
of H across the membrane, and F1, which is a multisubunit
protein that has the catalytic machinery for ATP synthesis
and hydrolysis. F1 can be detached from the membrane as
a soluble protein; it is formed by ¢ve di¡erent subunits K3, L3,
Q, N and O (for review see [1,2]). The mitochondrial ATP syn-
thase also has a 84 residue protein [3] that regulates the cata-
lytic properties of the enzyme; this protein is known as nat-
urally occurring ATPase inhibitor [4]. When particles devoid
of inhibitory protein or soluble F1 are incubated with the
inhibitory protein (IF1) at relatively acid pH and ATP, IF1
binds to F1 and inhibits its ATPase activity. In these recon-
stitution experiments, the stoichiometry of bound IF1 to F1 is
1 [5]. IF1 also inhibits ATP synthesis in submitochondrial
particles [6^8] ; in this case, the inhibitory action of IF1 is
removed by electrochemical H gradients, and thereby, allows
ATP synthesis.
The structure of IF1 has been extensively studied [9^11]. A
characteristic of IF1 is that at acid pH, two IF1 interact and
form a homodimer [12]. Other experiments have shown that
the incubation of soluble F1 with IF1 at acid pH and ATP
yields a dimeric enzyme formed by two F1^IF1 complexes
[13]. The authors suggested that IF1 dimerizes through anti-
parallel K-helical coiled-coil portions of their C-terminal re-
gion, and that their opposite N-terminal regions interact with
F1. In yeast mitochondria, it has also been shown that the
FoF1 ATP synthase may exist in dimers through a process
that is dependent on subunits e, g, and k [14,15]. However, it
is not known if in the mitochondrial membrane F1 in complex
with IF1 is a dimer formed by two F1^IF1 complexes.
The F1^IF1 complex may also be obtained from submito-
chondrial particles that have their F1 already in complex with
IF1 [16,17]. Thus, it was relevant to the mechanism of action
of IF1, and in consequence to the regulation of the catalytic
properties of FoF1, to examine if the naturally occurring F1^
IF1 complex in its soluble form is also a dimer. The results of
the studies showed that the solubilized form of the naturally
occurring F1^IF1 is a dimer that exists in equilibrium with
monomeric F1^IF1.
2. Materials and methods
Mitochondria from bovine hearts and Mg-ATP submitochondrial
particles were prepared as described in [18,19]. F1^IF1 was prepared
as in [19], except that the complex obtained from the Sepharose^hex-
ylammonium column was applied to a Superdex 200 HR FPLC col-
umn and eluted with 50 mM Tris^SO4 pH 6.5. The eluted F1^IF1
complex was concentrated in Centricon ¢lters to between 5 and 10
mg/ml, and stored at 370‡C. To determine the extent of control of the
hydrolytic activity of soluble and particulate F1 by IF1, the prepara-
tions were incubated in 50 mM Tris^SO4 pH 8.0, 2 mM EDTA, 100
mM KCl, and 10 mM ATP at 40‡C. At di¡erent incubation times
aliquots were withdrawn for assay of ATPase activities. The maximal
activities reached, in relation to the initial activities were considered
an index of control of either soluble or particulate F1 by IF1 [17]. The
basal activities of Mg-ATP particles and soluble F1^IF1 were around
0.4 and 2^3 Wmol/min/mg, respectively. At the maximal point of acti-
vation, activities were of the order of 7 and 70 Wmol/min/mg for
particulate and soluble F1, respectively. Soluble F1, free of IF1 was
prepared as described [20].
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2.1. Size exclusion chromatography
The determination of the molecular masses of F1 and F1^IF1 was
carried out in SEC4000 column. Soluble F1^IF1 and F1 at the indi-
cated protein concentrations were applied and eluted with 50 mM
Tris^SO4 pH 6.5, 10% glycerol, 0.02 mM sodium azide, 0.001% phen-
ylmethylsulfonyl £uoride, 10 mM MgSO4, and 1 mM EDTA. The £ux
rate was 1 ml/min; when required fractions were collected every 15 s.
The data were analyzed with Microcal Origin 5.0 and Jandel PeakFit.
Molecular weights were calculated according to the equation
Kav = (Ve3V0)/(Vt3V0), where Ve, V0 and Vt are protein elution vol-
ume, void volume and total column volume, respectively. The stan-
dards were: thyroglobulin, Q globulin, ovalbumin, myoglobin, vita-
min-B12 (670, 158, 44, 17, and 1.35 kDa, respectively). Plots of Kav
versus log (molecular weights) were linear with a correlation coe⁄-
cient of 0.98.
The samples of F1^IF1 for electron microscopy analysis were pre-
pared exactly as described [13], except that the grids were washed with
the bu¡er used in the gel ¢ltration experiments. This step was prior to
staining with 4% methylamine tungstate.
Protein was determined by the bicinchoninic acid method [21].
3. Results
Mg-ATP particles from bovine heart mitochondria were the
starting material for the preparation of the naturally occur-
ring F1^IF1. The particles had an ATPase activity of 0.4
Wmol/min/mg of protein. Their incubation in media with an
alkaline pH and salt increased their ATPase activity to a value
of 7 Wmol/min/mg. This is due to the removal of IF1 from its
inhibitory site in F1 [17]. Assuming that the F1^inhibitor
complex has no catalytic activity, the data indicate that about
95% of the population of particulate F1 was in complex with
IF1. This naturally occurring F1^IF1 complex was solubilized
from Mg-ATP particles and puri¢ed. In many preparations of
F1^IF1, we have seen that in SDS^PAGE, the enzyme exhib-
its the subunit composition of F1 plus the subunit that cor-
responds to the inhibitory protein. The basal ATPase activity
of soluble F1^IF1 was between 2 and 3 Wmol/min/mg. After
incubation in the activation media, activity reached a value of
60^70 Wmol/min/mg. Thus, particulate and soluble F1^IF1
exhibited the same characteristics.
Size exclusion chromatography of the F1^IF1 preparation
showed that the peak of maximal absorbance appeared with
7 ml of elution volume (Fig. 1) that corresponds to a molec-
ular mass of 670 kDa. We also determined the elution volume
of free F1. The peak of maximal absorbance was reached with
7.6 ml of elution volume. A mixture of F1 and F1^IF1 ex-
hibited two peaks that appeared with 7 and 7.6 ml. Because
the chromatographic system employed would not distinguish
between F1 (MW = 360 kDa) and a monomeric form of F1^
IF1 (MW = 370 kDa), the elution volume of F1 was the refer-
ence of the volume at which monomeric F1^IF1 elutes. Thus,
the chromatographic data indicated that the principal compo-
nent of F1^IF1 was a dimer.
Nonetheless, it is important to note in Fig. 1 that the elu-
tion pro¢le of the naturally occurring F1^IF1 was not sym-
metrical. It exhibited a clear shoulder in the volume at which
F1 eluted. The shoulder could be due to a contamination by
F1 in the F1^IF1 preparation, or to the existence of a fraction
in which F1^IF1 was in the monomeric state. The activity
data (see above) indicated that in soluble F1^IF1, the con-
tamination by free F1 was less than 5%. Thus, the clearly
apparent shoulder in the elution pro¢le of F1^IF1 suggested
that the preparation of soluble F1^IF1 was a mixture of di-
meric and monomeric F1^IF1 and that these two forms could
be interconvertible.
To assess if there is an equilibrium between dimers and
monomers of F1^IF1, three di¡erent amounts of F1^IF1
were passed though the size exclusion chromatographic col-
umn (Fig. 2). The elution pro¢le of 350 and 100 Wg showed
that the peak of maximal absorbance appeared with very sim-
ilar volumes; however, the asymmetry of the elution curve
Fig. 1. Elution pro¢les of soluble F1^IF1, F1 and a mixture of the
two enzymes (dashed, solid and dotted lines, respectively). For each
of the three samples, the maximal absorbance was normalized to 1.
The inset shows plots of Kav against the log of the molecular weight
of standards and the point of maximal absorbance of (1) F1 and
(2) F1^IF1.
Fig. 2. Elution pro¢le of F1^IF1 at di¡erent concentrations. The
solid, dashed, and dotted lines indicate the pro¢le when 350, 100,
and 16 Wg in volumes of 35, 10, and 50 Wl respectively, were applied
to the SEC4000 column. For each of the three samples, the maxi-
mal absorbance observed was normalized to 1. Data of the elution
maxima and the relative amounts of dimer (D) and monomer (M)






adjusted to a non-linear Gaussian ¢t: where y is absorbance,
a0 = area, a1 = center of the area, a2 = width, and x is elution vol-
ume.
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with the lower concentration was more marked. Moreover,
when 16 Wg was applied, the peak of maximal elution ap-
peared in the region of ‘monomeric F1^IF1’. The deconvolu-
tion of the elution curves (inset Fig. 2) showed that at the
higher concentrations, the naturally occurring F1^IF1 con-
sisted of dimers and monomers, the concentration of the latter
being higher at the lower protein concentrations. With the
lowest concentration of F1^IF1 applied, the enzyme eluted
essentially as ‘monomeric F1^IF1’.
The nature of the protein fraction that elutes as what we
have called ‘monomeric F1^IF1’ deserves a further comment.
Dimeric F1^IF1 could have dissociated into two complexes
each formed by 1 F1 with 1 IF1. Alternatively, if dimers of
IF1 do not dissociate, the fraction could represent a mixture
of 1 F1 in complex with dimeric IF1 and free F1. In this
respect, it is noted that the speci¢c activity of this protein
fraction was around 2 Wmol/min/mg and that after activation,
it reached a value of at least 70 Wmol/min/mg. This indicated
that almost the totality of F1 was inhibited by IF1. Therefore,
it would seem that dimeric F1^IF1 dissociated into mono-
meric F1^IF1.
In the work that described that reconstituted F1^IF1 is a
dimer, Cabezon et al. [13] included micrographs that showed
that about 70% of the population of F1^IF1 was in the di-
meric form. With the same methodology we examined the
fraction of F1^IF1 that eluted from the size exclusion column
as dimers, and that that eluted as monomeric F1^IF1. In the
former, the number of structures that appeared as dimers was
signi¢cantly higher than in the fraction that corresponded to
monomeric F1^IF1 (Fig. 3B,D versus A,C). However, the
abundance of dimers in this fraction was relatively low, ap-
proximately 20% of the total population. It is noted that in
the preparation of the samples for electron microscopy, F1^
IF1 had to be diluted 1000-fold. According to the data in Fig.
2, at this concentration, F1^IF1 would be essentially in the
monomeric form. This could account for the relatively low
abundance of dimeric F1^IF1.
4. Discussion
The ATPase activity of Mg-ATP particles is less than 5% of
the maximal activity that is reached after removal of the in-
hibitory action of IF1; thus, in these particles more than 95%
of their F1 are in complex with IF1. When this natural form
of F1^IF1 is solubilized and puri¢ed, the resulting preparation
is formed by dimers of F1^IF1 that at pH 6.5 are in equilib-
rium with F1^IF1 monomers. A central question that arises
from these studies is whether the ¢ndings are related to the
regulation of the catalytic properties of particulate FoF1. It
has been estimated that in the mitochondrial membrane the
ratio of F1 to IF1 is 1 [5]. In solutions of relatively acid pH,
soluble IF1 exists almost exclusively as dimers [13]. If this
situation also holds for IF1 in the membrane and the ratio
of IF1 monomers to F1 is 1, complete abolition of ATPase
activity by IF1 requires that an IF1 dimer interacts with two
F1, yielding a dimer of two F1^IF1 complexes. On the other
hand, if in the membranes monomeric IF1 is the active spe-
cies, with a 1:1 stoichiometry of IF1 to F1, full inhibition of
F1 could be achieved without obligatory dimerization of two
F1^IF1 complexes. In this context, it is noteworthy that a
fragment of IF1 that contains the inhibitory residues, but
lack the amino acid sequence required for dimerization is a
good inhibitor of F1 [22].
As shown here, the monomeric and dimeric forms of F1^
IF1 are in equilibrium. Thus, it may also be asked if the
proton motive force induced transition of F1^IF1 to the cat-
alytically active form of F1 [6^8] involves a shift in the equi-
librium between dimers and monomers of F1^IF1, or whether
it merely involves a displacement of monomeric IF1 from its
inhibitory site in monomeric F1 [23,24]. Along this line, it is
Fig. 3. Electron micrographs of dimeric and monomeric F1^IF1. The fractions of F1^IF1 that eluted from the size exclusion chromatography
(Fig. 1) as monomers (A and C) and as dimers (B and D) were analyzed by electron microscopy as described in Section 2. The arrows in B
and D indicate dimers. Magni¢cation in A and B was 120 000 and in C and D, 200 000. Bar in A and B = 100 nm, in C and D = 50 nm.
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recalled that IF1 binds to other proteins of the mitochondrial
membrane [25,26]. Thus, the ¢ndings that FoF1 complexes
may dimerize through subunits e, g, and k [14,15] and that
soluble F1^IF1 undergoes reversible dimerization raises new
questions as to the contribution of macromolecular complexes
to the process of energy conservation during oxidative phos-
phorylation.
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